Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Muscle-invasive Bladder Cancer × enfortumab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Peripheral Nervous System Diseases 1 Muscle-invasive Bladder Cancer 1 Endometrial Neoplasms 1 Advanced Solid Tumor 1 Advanced Bladder Cancer 1

Interventions

Drug Therapy 2 pembrolizumab 1 enfortumab vedotin 1 Watchful Waiting 1 Radiotherapy 1 Palliative Care 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07475806 2026-03-17

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

Astellas Pharma Inc

Phase 2 Not yet recruiting

Muscle-invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡